Alphavirus replicon vectors have been used in successful immunization and challenge experiments for a wide range of pathogens in rodent, avian, equine and primate species. Especially in acute infection models, these vectors, expressing immunizing genes from pathogenic viruses, have demonstrated the capacity for strong and protective immunization. A Phase I clinical trial with a Venezuelan equine encephalitis virus (VEE) replicon vaccine, expressing the gag gene from clade C human immunodeficiency virus (HIV), was initiated in 2003. We propose an analogous alphavirus replicon vaccine approach using immunizing genes of the SARS coronavirus (SARS-CoV) to develop a safe and effective vaccine against this virus. Specifically, we will 1) Clone the E, M, N and S genes of the SARS coronavirus, as well as X ORFs 1-5, into VEE and South African Arbovirus 86 (AR86) replicon vectors and evaluate these immunogens in mice, ferrets and nonhuman primate models, 2) Produce and test alternative forms of SARS immunogens, including SARS virus-like particles (SARS-VLP), for potential use in second generation vaccines, and 3) Clone and express native and mutated forms of the SARS coronavirus ORFs X1 and X3, interferon antagonist genes, from alphavirus replicon vectors for reagent production and as potential vaccine components. In Preliminary Studies we have expressed all the SARS-CoV structural and X ORF genes in the context of the VEE vectors, have demonstrated the induction of neutralizing antibodies in mice with the S construct, and have early evidence of SARS-VLP production using the baculovirus expression system in Sf9 cells. This overall development program is designed to rapidly produce a safe and effective vaccine candidate based on the alphavirus vectors as well as provide refinements for use in second generation vaccines for SARS-CoV.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI059443-05
Application #
7760881
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-02-01
Budget End
2010-01-31
Support Year
5
Fiscal Year
2009
Total Cost
$295,521
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Gonzalez, P N; Pavlicev, M; Mitteroecker, P et al. (2016) Genetic structure of phenotypic robustness in the collaborative cross mouse diallel panel. J Evol Biol 29:1737-51
Sheahan, Timothy; Whitmore, Alan; Long, Kristin et al. (2011) Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus. J Virol 85:217-30
Rockx, Barry; Donaldson, Eric; Frieman, Matthew et al. (2010) Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus. J Infect Dis 201:946-55
Frieman, Matthew B; Chen, Jun; Morrison, Thomas E et al. (2010) SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. PLoS Pathog 6:e1000849
Zornetzer, Gregory A; Frieman, Matthew B; Rosenzweig, Elizabeth et al. (2010) Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection. J Virol 84:11297-309
Eckerle, Lance D; Becker, Michelle M; Halpin, Rebecca A et al. (2010) Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog 6:e1000896
Brooke, Christopher B; Deming, Damon J; Whitmore, Alan C et al. (2010) T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody. J Virol 84:4556-68
Li, Kelvin; Venter, Eli; Yooseph, Shibu et al. (2010) ANDES: Statistical tools for the ANalyses of DEep Sequencing. BMC Res Notes 3:199
Frieman, Matthew; Ratia, Kiira; Johnston, Robert E et al. (2009) Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J Virol 83:6689-705
Rockx, Barry; Baas, Tracey; Zornetzer, Gregory A et al. (2009) Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J Virol 83:7062-74

Showing the most recent 10 out of 37 publications